Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis - Voskaridou, E; Christoulas, D; Antoniadou, L; Terpos, E (Acta Haematol, 2008)